You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | n/a | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | n/a | -59.2% |
| ROCE | n/a |
| Latest | Forecast | |
|---|---|---|
| P/E | n/a | 0.0 |
| PEG | n/a | -999,999.0 |
| Price / Revenue | n/a | 8.3 |
| Price / Book value | n/a |
| Latest | Forecast | |
|---|---|---|
| Revenue | 0.0% | -3.6% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | 10,232.5% |
| DPS | 0.0% | 0.0% |
| Year Ending | Revenue ($m) |
Pre-tax ($m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2015-12-31 | 9.29 | -1.45 | $-1.86 | 0.0 | 0.0 | n/a | n/a | 0.0% |
| 2016-12-31 | 12.27 | -3.35 | $-0.11 | -15.4 | 0.0 | n/a | n/a | 0.0% |
| 2017-12-31 | 13.98 | -9.92 | $-0.20 | -16.3 | 0.0 | n/a | n/a | 0.0% |
| 2018-12-31 | 16.67 | -8.87 | $-0.17 | -14.2 | 0.0 | n/a | n/a | 0.0% |
| 2019-12-31 | 21.62 | -12.89 | $-0.23 | -7.2 | 0.0 | n/a | n/a | 0.0% |
| Year Ending | Revenue ($m) |
Pre-tax ($m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2020-12-31 | 18.19 | -10.77 | -16.04p | 0.0 | n/a | 0% | 0.00p | 0.0% |
| 2021-12-31 | 21.94 | -6.61 | 0.00p | 0.0 | n/a | 0% | 0.00p | 0.0% |
| MaxCyte to consolidate stock to single trading line Sharecast News | 21 Feb |
|---|---|
| MaxCyte 'exceptionally positive' following strong FY trading performance Sharecast News | 20 Jan |
| MaxCyte inks new development agreement with KSQ Therapeutics Sharecast News | 04 Dec |
| APEIRON Biologics Clinical and Commercial License | 08-Jul-20 07:05 |
|---|---|
| Block Listing Return & TVR | 01-Jul-20 07:04 |
| Holding(s) in Company | 02-Jun-20 17:55 |
| Holding(s) in Company | 28-May-20 15:35 |
| Holding(s) in Company | 26-May-20 17:52 |